FR2959668B1 - Association pharmaceutique contenant l'acide lipoique, l'acide hydroxycitrique et une somatostatine a titre de principes actifs - Google Patents

Association pharmaceutique contenant l'acide lipoique, l'acide hydroxycitrique et une somatostatine a titre de principes actifs

Info

Publication number: FR2959668B1
Authority: FR; France
Prior art keywords: acid; somatostatin; active ingredients; pharmaceutical association; hydroxycitric
Prior art date: 2010-05-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR1053504A

Other languages

English (en)

Other versions

FR2959668A1 (fr

Inventor

Laurent Schwartz

Adeline Guais-Vergne

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

BIOREBUS

Original Assignee

BIOREBUS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-05-05

Filing date

2010-05-05

Publication date

2012-07-13

2010-05-05 Application filed by BIOREBUS filed Critical BIOREBUS

2010-05-05 Priority to FR1053504A priority Critical patent/FR2959668B1/fr

2011-05-05 Priority to PCT/FR2011/051025 priority patent/WO2011138565A1/fr

2011-11-11 Publication of FR2959668A1 publication Critical patent/FR2959668A1/fr

2012-07-13 Application granted granted Critical

2012-07-13 Publication of FR2959668B1 publication Critical patent/FR2959668B1/fr

Status Expired - Fee Related legal-status Critical Current

2030-05-05 Anticipated expiration legal-status Critical

Links

AGBQKNBQESQNJD-ZETCQYMHSA-N (S)-lipoic acid Chemical compound OC(=O)CCCC[C@H]1CCSS1 AGBQKNBQESQNJD-ZETCQYMHSA-N 0.000 title 1
ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 title 1
102000005157 Somatostatin Human genes 0.000 title 1
108010056088 Somatostatin Proteins 0.000 title 1
239000004480 active ingredient Substances 0.000 title 1
229940089491 hydroxycitric acid Drugs 0.000 title 1
235000019136 lipoic acid Nutrition 0.000 title 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title 1
229960000553 somatostatin Drugs 0.000 title 1
229960002663 thioctic acid Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

FR1053504A 2010-05-05 2010-05-05 Association pharmaceutique contenant l'acide lipoique, l'acide hydroxycitrique et une somatostatine a titre de principes actifs Expired - Fee Related FR2959668B1 (fr)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
FR1053504A FR2959668B1 (fr)	2010-05-05	2010-05-05	Association pharmaceutique contenant l'acide lipoique, l'acide hydroxycitrique et une somatostatine a titre de principes actifs
PCT/FR2011/051025 WO2011138565A1 (fr)	2010-05-05	2011-05-05	Association pharmaceutique contenant l'acide lipoïque, l'acide hydroxycitrique et une somatostatine a titre de principes actifs

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR1053504A FR2959668B1 (fr)	2010-05-05	2010-05-05	Association pharmaceutique contenant l'acide lipoique, l'acide hydroxycitrique et une somatostatine a titre de principes actifs

Publications (2)

Publication Number	Publication Date
FR2959668A1 FR2959668A1 (fr)	2011-11-11
FR2959668B1 true FR2959668B1 (fr)	2012-07-13

Family

ID=42735757

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR1053504A Expired - Fee Related FR2959668B1 (fr)	2010-05-05	2010-05-05	Association pharmaceutique contenant l'acide lipoique, l'acide hydroxycitrique et une somatostatine a titre de principes actifs

Country Status (1)

Country	Link
FR (1)	FR2959668B1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1486495B1 (fr) *	1998-10-26	2009-12-09	The Research Foundation of State University of New York	Sels de dérives de l'acide lipoique et leur utilisation dans le traitement des maladies
US6284786B1 (en) *	1999-02-16	2001-09-04	The Center For The Improvement Of Human Functioning, Int'l., Inc.	Treatment of cancer using lipoic acid in combination with ascorbic acid
IT1312060B1 (it) *	1999-04-09	2002-04-04	Antibioticos Spa	Uso dell'acido alfa lipoico nel trattamento antimetastatico.
CA2525367A1 (fr) *	2003-05-09	2004-11-25	The Trustees Of The University Of Pennsylvania	Utilisation d'inhibiteurs de la citrate lyase et d'inhibiteurs du transporteur de tricarboxylate dans le traitement du cancer
WO2009008461A1 (fr) *	2007-07-10	2009-01-15	Griffin Biotech, Ltd.	Composition pharmaceutique pour une maladie provoquée par une prolifération de cellule sensible aux hormones sexuelles

2010
- 2010-05-05 FR FR1053504A patent/FR2959668B1/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
FR2959668A1 (fr)	2011-11-11

Similar Documents

Publication	Publication Date	Title
EP2768539A4 (fr)	2015-11-18	Préparations antimicrobiennes contenant de l'acide pélargonique
DOP2012000011A (es)	2012-02-29	Formulacion farmaceutica
EP2583684A4 (fr)	2014-01-08	Peptide ayant une activité antimicrobienne ou anti-inflammatoire et composition pharmaceutique le contenant en tant que principe actif
MX377553B (es)	2025-03-10	Composicion farmaceutica estable y metodos de uso de la misma.
EA201201050A1 (ru)	2013-02-28	Пиразолы в качестве антагонистов crth2
HRP20240168T1 (hr)	2024-04-26	Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije
EP2144609A4 (fr)	2010-06-16	Formulations pharmaceutiques contenant des dérivés d'acide lipoïque
EP2871180A4 (fr)	2016-02-24	Dérivé d'ester d'acide 2-aminonicotinique et bactéricide le contenant comme principe actif
EP2740729A4 (fr)	2015-02-25	Dérivé de quinazoline, composition pharmaceutique contenant le composé, et utilisation du dérivé dans la préparation d'un médicament
EA201291089A1 (ru)	2013-05-30	Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций
EP2307056A4 (fr)	2013-11-27	Compositions pharmaceutiques aqueuses stables contenant du paracetamol
EP3228311A3 (fr)	2018-01-10	Compositions pharmaceutiques et nutritionnelles de l'acide abscisique
WO2011089234A8 (fr)	2012-09-07	Procédé et composition
EP2787071A4 (fr)	2015-06-24	Agent d'augmentation de la concentration d'équol contenant du psicose comme principe actif
FR2981572B1 (fr)	2018-01-19	Compositions pharmaceutiques d'acide ursodesoxycholique
ME02405B (fr)	2016-09-20	Composés de pyrazole utilisés en tant qu'inhibiteurs de sglt1
TN2013000386A1 (en)	2015-01-20	Suspension type topical formulations comprising cyclic depsipeptide
EP2558077A4 (fr)	2014-01-01	Composition pharmaceutique orale comprenant de l'acide fénofibrique et un agent alcalinisant
EP2214680A4 (fr)	2010-12-29	Formulation pharmaceutique de l'acide clavulanique
EP2928462A4 (fr)	2016-06-01	Procédés d'administration de compositions comprenant de l'acide docosapentaénoïque
EA201490573A1 (ru)	2014-06-30	Соединение бензотиазолона
FR2937867B1 (fr)	2011-03-04	Association pharmaceutique contenant l acide lipoique et l acide hydroxycitrique a titre de principes actifs.
EP2641604A4 (fr)	2014-06-18	Composition contenant un styraxlignolide a ou son aglycone à titre de principe actif pour prévenir ou traiter l'asthme
ZA201404068B (en)	2015-04-29	The use of silver(i) complexes as active pharmaceutical ingredients (api's) iincluding anticancer agents
FR2959668B1 (fr)	2012-07-13	Association pharmaceutique contenant l'acide lipoique, l'acide hydroxycitrique et une somatostatine a titre de principes actifs

Legal Events

Date	Code	Title	Description
2014-03-07	ST	Notification of lapse	Effective date: 20140131